Rosen代表 ADMA Biologics, Inc.（纳斯达克股票代码：ADMA） 的股东对潜在的证券索赔进行调查

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) resulting from allegations that ADMA Biologics may have issued materially misleading business information to the investing public. SO WHAT: If you purchased ADMA Biologics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

该内容为新闻快讯，正文已简化。